Abstract
Nonalcoholic fatty liver disease (NAFLD) is the leading chronic liver disease worldwide. Its more advanced subtype, nonalcoholic steatohepatitis (NASH), connotes progressive liver injury that can lead to cirrhosis and hepatocellular carcinoma. Here we provide an in-depth discussion of the underlying pathogenetic mechanisms that lead to progressive liver injury, including the metabolic origins of NAFLD, the effect of NAFLD on hepatic glucose and lipid metabolism, bile acid toxicity, macrophage dysfunction, and hepatic stellate cell activation, and consider the role of genetic, epigenetic, and environmental factors that promote fibrosis progression and risk of hepatocellular carcinoma in NASH.
Keywords
BiologyNonalcoholic fatty liver diseaseFatty liverDiseaseNonalcoholic steatohepatitisInternal medicine
MeSH Terms
CarcinomaHepatocellularHumansLiverLiver CirrhosisLiver NeoplasmsNon-alcoholic Fatty Liver Disease
Affiliated Institutions
Related Publications
Nonalcoholic Steatohepatitis
Nonalcoholic fatty liver disease (NAFLD) is being increasingly recognized as a common liver disorder that represents the hepatic manifestation of the metabolic syndrome, a varia...
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis in the absence of a history of significant alcohol use or other known liver disease. Nonalcoholic ...
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
Aliment Pharmacol Ther 2011; 34: 274–285 Summary Background Non‐alcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease, and its worldwide prevalence co...
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Nonalcoholic fatty liver disease (NAFLD) has been associated with the insulin–resistance syndrome, at present defined as the metabolic syndrome, whose limits were recently set. ...
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
These recommendations are based on the following: (1) a formal review and analysis of the recently published world literature on the topic [Medline search up to June 2011]; (2) ...
Publication Info
- Year
- 2021
- Type
- review
- Volume
- 184
- Issue
- 10
- Pages
- 2537-2564
- Citations
- 1619
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1619
OpenAlex
44
Influential
1509
CrossRef
Cite This
Rohit Loomba,
Scott L. Friedman,
Gerald I. Shulman
(2021).
Mechanisms and disease consequences of nonalcoholic fatty liver disease.
Cell
, 184
(10)
, 2537-2564.
https://doi.org/10.1016/j.cell.2021.04.015
Identifiers
- DOI
- 10.1016/j.cell.2021.04.015
- PMID
- 33989548
- PMCID
- PMC12168897